http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#Head
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#assertion
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#provenance
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#pubInfo
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#assertion
http://purl.obolibrary.org/obo/MONDO_0100081
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/MONDO_0100081
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/DRUGBANK:DB01142
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
http://www.w3.org/2000/01/rdf-schema#label
Among TCAs, doxepin (sinequan) appears to be best suited for managing insomnia in healthy adults. Doxepin works as a selective antagonist to H(1) receptors, which promote the initiation and maintenance of sleep (Owen, 2009) (Table 2). Ultra-low doses of this drug (< 6 mg per day) significantly improve and sustain both maintenance and duration of sleep (Rojas-Fernandez and Chen, 2014; Weber et al., 2010). Another frequently prescribed TCA is amitriptyline, which as a long-term option is found to be effective for patients with ongoing sleep problems (Everitt et al., 2014; Pagel and Parnes, 2001).
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
https://w3id.org/biolink/vocab/has_population_context
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#context
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
https://w3id.org/biolink/vocab/publications
https://pubmed.ncbi.nlm.nih.gov/31622593
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/OffLabelIndication
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#context
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
https://w3id.org/biolink/vocab/Cohort
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#context
http://www.w3.org/2000/01/rdf-schema#label
Adults
https://identifiers.org/DRUGBANK:DB01142
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#provenance
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-08-16T20:58:19.629539
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#pubInfo
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#sig
http://purl.org/nanopub/x/hasSignature
dQLrGebw1x7RtUmh3dbS4NpT5gUdN48SmRVQNHc64d2GTsTILdtkPFOcjoEAk6hJjcVSxD5EJFhU8ob96i+QihxDyIezY0GfdjPwsCP3IJWClQ9pvIFVD80uI/lqc8HmbxfdL+SHph3VrxG8pkC+l1tPNux0iSKoqfUXYOg0hy4=
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
http://www.w3.org/ns/prov#generatedAtTime
2021-08-16T20:58:19.629539
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAu9H56k9QjpLnl5LVawV8-Y0zpILe9e755eeTuFbmE7Y
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY